AR240175A1 - Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma. - Google Patents

Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma.

Info

Publication number
AR240175A1
AR240175A1 AR312348A AR31234888A AR240175A1 AR 240175 A1 AR240175 A1 AR 240175A1 AR 312348 A AR312348 A AR 312348A AR 31234888 A AR31234888 A AR 31234888A AR 240175 A1 AR240175 A1 AR 240175A1
Authority
AR
Argentina
Prior art keywords
cell line
monoclonal antibody
hybridoma technique
antibody derived
line produced
Prior art date
Application number
AR312348A
Other languages
English (en)
Spanish (es)
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of AR240175A1 publication Critical patent/AR240175A1/es

Links

Classifications

    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G15/00—Apparatus for electrographic processes using a charge pattern
    • G03G15/65—Apparatus which relate to the handling of copy material
    • G03G15/6517—Apparatus for continuous web copy material of plain paper, e.g. supply rolls; Roll holders therefor
    • G03G15/6526—Computer form folded [CFF] continuous web, e.g. having sprocket holes or perforations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G15/00—Apparatus for electrographic processes using a charge pattern
    • G03G15/14—Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base
    • G03G15/16—Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base of a toner pattern, e.g. a powder pattern, e.g. magnetic transfer
    • G03G15/1695—Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base of a toner pattern, e.g. a powder pattern, e.g. magnetic transfer with means for preconditioning the paper base before the transfer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00367—The feeding path segment where particular handling of the copy medium occurs, segments being adjacent and non-overlapping. Each segment is identified by the most downstream point in the segment, so that for instance the segment labelled "Fixing device" is referring to the path between the "Transfer device" and the "Fixing device"
    • G03G2215/00409—Transfer device
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00443—Copy medium
    • G03G2215/00451—Paper
    • G03G2215/00455—Continuous web, i.e. roll
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00443—Copy medium
    • G03G2215/00451—Paper
    • G03G2215/00455—Continuous web, i.e. roll
    • G03G2215/00459—Fan fold, e.g. CFF, normally perforated
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00535—Stable handling of copy medium
    • G03G2215/00607—Debris handling means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR312348A 1987-11-02 1988-10-14 Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma. AR240175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/116,514 US5002869A (en) 1987-11-02 1987-11-02 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes

Publications (1)

Publication Number Publication Date
AR240175A1 true AR240175A1 (es) 1990-02-28

Family

ID=22367627

Family Applications (1)

Application Number Title Priority Date Filing Date
AR312348A AR240175A1 (es) 1987-11-02 1988-10-14 Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma.

Country Status (13)

Country Link
US (1) US5002869A (zh)
EP (1) EP0387286B1 (zh)
JP (1) JP3158119B2 (zh)
CN (1) CN1033074A (zh)
AR (1) AR240175A1 (zh)
AU (1) AU618563B2 (zh)
CA (1) CA1305928C (zh)
DE (1) DE3855201T2 (zh)
ES (1) ES2017806A6 (zh)
IE (1) IE62056B1 (zh)
IL (1) IL88160A0 (zh)
WO (1) WO1989004175A1 (zh)
ZA (1) ZA887771B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2095876T3 (es) * 1989-06-02 1997-03-01 Univ Johns Hopkins Med Anticuerpos monoclonales contra la cadena beta de receptores de adhesion de leucocitos; procedimiento de produccion de estos anticuerpos y utilizacion
US5100378A (en) * 1989-06-09 1992-03-31 Neorx Corporation Enhancement of target cell localization of lymphoid cells
NZ236792A (en) * 1990-01-19 1993-05-26 Merck & Co Inc Recombinant human anti-cd18 antibody, murine 1b4 heavy or light chain variable region, dna, vectors, mammalian host and pharmaceutical compositions
US5273738A (en) * 1990-03-03 1993-12-28 Fred Hutchinson Cancer Research Center Radiation delivery to lymphoid and marrow tissues
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
US5223241A (en) * 1990-10-01 1993-06-29 The General Hospital Corporation Method for early detection of allograft rejection
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
WO1994004188A1 (en) * 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
FR2700471B1 (fr) * 1993-01-21 1995-04-07 Pasteur Merieux Serums Vacc Utilisation d'anticorps monoclonaux anti-LFA-1 pour la préparation d'un médicament destiné à prévenir le rejet des greffes d'organes solides et médicaments obtenus.
DE69433789T2 (de) * 1993-03-19 2005-06-23 Allen, Allen D., Los Angeles Methoden zur inhibition von hiv-assotiierte krankheit mittels monoklonaler antikörper gegen sich selbst gerichtete zytotoxische t-zellen
US6534057B2 (en) 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
US5651970A (en) * 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
EP0831907A4 (en) * 1995-06-06 2005-05-04 D Allen Allen METHOD FOR TREATING MOLLUSCUM CONTAGIOSUM AS A RESULT OF HIV INFECTION
US6001356A (en) * 1995-09-29 1999-12-14 Rush-Presbyterian-St. Luke's Medical Center Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
DE60042735D1 (de) 1999-03-19 2009-09-24 Genentech Inc Behandlung von lfa-1 assozieerten krankheiten durch gesteigerte dosen von lfa-1 antagonist
US6582698B1 (en) * 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
US6919077B2 (en) * 2002-09-27 2005-07-19 Aids Research, Llc LFA-1 alpha subunit antibodies and methods of use
CA2563432A1 (en) * 2004-04-16 2005-12-01 Genentech, Inc. Method for augmenting b cell depletion
RU2006146939A (ru) * 2004-06-09 2008-07-20 Дженентек Способ лечения кольцевидной гранулемы или саркоида
US7789282B2 (en) * 2007-08-14 2010-09-07 Chervon Limited Nailer device
US20150079075A1 (en) * 2011-09-15 2015-03-19 Cytodyn Inc. Anti-CD11A Antibodies and Uses Thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
GB8605316D0 (en) * 1986-03-04 1986-04-09 Royal Free Hosp School Med Immunosuppression
WO1988005592A1 (en) * 1987-01-24 1988-07-28 Dai Nippon Insatsu Kabushiki Kaisha Optical recording medium and production thereof

Also Published As

Publication number Publication date
AU2611488A (en) 1989-06-01
ZA887771B (en) 1990-06-27
IE62056B1 (en) 1994-12-14
EP0387286A4 (en) 1990-10-10
CA1305928C (en) 1992-08-04
IL88160A0 (en) 1989-06-30
JP3158119B2 (ja) 2001-04-23
DE3855201T2 (de) 1996-09-05
AU618563B2 (en) 1992-01-02
CN1033074A (zh) 1989-05-24
JPH03501804A (ja) 1991-04-25
ES2017806A6 (es) 1991-03-01
EP0387286A1 (en) 1990-09-19
EP0387286B1 (en) 1996-04-10
WO1989004175A1 (en) 1989-05-18
US5002869A (en) 1991-03-26
DE3855201D1 (de) 1996-05-15
IE883062L (en) 1989-05-02

Similar Documents

Publication Publication Date Title
AR240175A1 (es) Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma.
DE68914244D1 (de) Monoklonaler Antikörper.
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
DK473887A (da) Hybridomacellelinie, monoklonalt antistof, fremgangsmaade til fremstilling af og anvendelse af det monoklonale antistof
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE3879452D1 (de) Chimaere antikoerper.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
NO822853L (no) Antigenbestemmelse.
DE3885355D1 (de) Monoklonale Antikörper.
NO162797C (no) Monoklonalt antistofff for anvendelse in vitro.
DK191989D0 (da) Tumor-associeret glycoproteinantigen, antistoffer mod antigenet samt hybridoma-cellelinie, der producerer antistofferne
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
DE3583341D1 (de) Leberwurm-antigene.
DK557289A (da) Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DE3888437D1 (de) Immobilisierte Antikörper.
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
FI885956A (fi) Monoklonaliska antikroppar mot lungkarcinom.
NO873488L (no) Monoklonale antistoffer.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO890116L (no) Monoklonale antistoffer.
DE69023717D1 (de) Monoklonaler Antikörper.
FI893928A0 (fi) Monoklonala motkroppar.
IT8821702A0 (it) Nuovo anticorpo monoclonale.
MX12068A (es) Linea celular producida mediante una tecnica de hibridoma y anticuerpo monocional obtenido.